S-1 · resale registration
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
TPST$0.4639-1.72%
Tempest Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$7.84M
Float & O/S:
Inst Own:
DilutionScan read 45 of Tempest Therapeutics, Inc.'s SEC filings and found 14 warrant series, 2 ATM programs, 1 equity line, 5 shelf registrations, 1 S-1 registration and 5 completed offerings on file for TPST. The latest dilution event on file is a registration statement on Oct 1, 2026. Analysis updated Oct 6, 2026.
Signal8 Summary
TPST
Going-concern warning, cash nearly gone
Snapshot
Tempest is a clinical-stage cancer and cell-therapy biotech with no revenue, losing $26.3M in FY 2025 and burning through cash.
What's Happening Right Now
- : A special stockholder meeting to remove supermajority voting requirements was adjourned to August 17, 2026 after insufficient votes were cast to approve the charter change.
- : Q2 2026 net loss was $5.2M, cash fell to just $0.8M from $7.7M at year-end, but the company reported a 100% complete response rate across 15 patients in an early CAR-T trial and named new board members and a business development lead.
- : Tempest partnered with Senlang Biotechnology to co-develop TPST-4003, a CD7-targeted in vivo CAR-T candidate, starting with a small investigator-led trial in China for autoimmune disease patients.
- : A prospectus filing tied to warrant resales disclosed that the company's auditors have raised substantial doubt about its ability to continue as a going concern.
- : Stockholders approved issuing up to roughly 4.2 million new shares tied to warrant exercises under Nasdaq rules.
Raise routes on file: effective shelf + effective S-1 + active equity line · latest dilution event 33 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Oct 1, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
Warrant
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Series A Warrants ( March 2026 PIPE)
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Series B Warrants ( March 2026 PIPE)
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
New Warrants ( May 2026 inducement)
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Placement Agent Warrants ( May 2026 inducement)
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ATM program
Issued 2021
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2024
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
Equity line
Issued 2026
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Registered direct offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your TPST trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
